Anti-Alpha Synuclein Antibody (pSer129) [J18]

(No reviews yet) Write a Review
SKU:
STMA00206
Antibody Type:
Recombinant Monoclonal
Applications:
ELISA
Applications:
WB
Applications:
ICC
Applications:
IHC
Reactivity:
Human
Reactivity:
Mouse
Host Species:
Rabbit
Isotype:
IgG
  • Immunohistochemistry analysis using Rabbit Anti-Alpha Synuclein pSer129 Monoclonal Antibody, Clone J18 (STMA00206). Tissue: Brain. Species: Mouse. Primary Antibody: Rabbit Anti-Alpha Synuclein pSer129 Monoclonal Antibody (STMA00206) at 1:10000. Secondary Antibody: anti-rabbit HRP. C57/BL6 mice were injected with 5 ug sonicated mouse recombinant alpha synuclein PFFs at 8 weeks of age.
  • Immunocytochemistry/Immunofluorescence analysis using Rabbit Anti-Alpha Synuclein (pSer129) Monoclonal Antibody, Clone J18 (STMA00206). Tissue: iPSC-derived neurons. Species: Human. Primary Antibody: Rabbit Anti-Alpha Synuclein (pSer129) Monoclonal Antibody (STMA00206) at 1:1000 for O/N at 4°C. Secondary Antibody: Anti-Rabbit: A488 at 1:1000 for 1 hour at RT. Magnification: 40X. Nuclear stain: Hoechst- 20 min, RT (blue).
  • Immunohistochemistry analysis using Rabbit Anti-Alpha Synuclein pSer129 Monoclonal Antibody, Clone J18 (STMA00206). Tissue: Brain. Species: Mouse. Primary Antibody: Rabbit Anti-Alpha Synuclein pSer129 Monoclonal Antibody (STMA00206) at 1:10000. Secondary Antibody: anti-rabbit HRP. C57/BL6 mice were injected with sonicated recombinant mouse alpha synuclein monomers or fibrils at 8 weeks of age.
  • Immunocytochemistry / Immunofluorescence analysis of human iPSC-derived neurons (Stem Cell Catalog Code ASE-9321KF) treated with 2.5µg ATTO 594 labeled type I alpha-synuclein pre-formed fibrils for up to 14 days. Cells seeded at 8k cells per well. Green: mouse anti-alpha synuclein (pSer129) monoclonal antibody (STMA00206) 1:5000; Red: alpha-synuclein PFFs; Pink: actin; Blue: Hoechst / DNA.
  • Dot Blot analysis using Rabbit Anti-Alpha Synuclein pSer129 Monoclonal Antibody, Clone J18 (STMA00206). Tissue: alpha synuclein peptide. Primary Antibody: Rabbit Anti-Alpha Synuclein pSer129 Monoclonal Antibody (STMA00206) at 1:500 for 2 hours at RT with shaking. Secondary Antibody: Goat anti-rabbit IgG:HRP at 1:4000 for 1 hour at RT with shaking. Phospho peptide sequence: AYEMP-pS-EEGYQ. Non-phospho peptide sequence: AYEMPSEEGYQ.
  • Western Blot analysis of Human Alpha Synuclein showing detection of Alpha Synuclein pSer129 protein using Rabbit Anti-Alpha Synuclein pSer129 Monoclonal Antibody, Clone J18 (STMA00206). Lane 1: MW ladder. Lane 2: 0.5 ug human alpha synuclein monomer. Lane 3: 2 ug human alpha synuclein monomer. Lane 4: 0.5 ug human alpha synuclein PFFs. Lane 5: 2 ug human alpha synuclein PFFs. Lane 6: 15 ug human Parkinson's Disease brain lysate.
  • Western Blot analysis of Mouse Brain showing detection of Alpha Synuclein pSer129 protein using Rabbit Anti-Alpha Synuclein pSer129 Monoclonal Antibody, Clone J18 (STMA00206). Lane 1: MW ladder. Lane 2: Mouse brain. Load: 15 ug. Block: 5% BSA in TBST. Primary Antibody: Rabbit Anti-Alpha Synuclein pSer129 Monoclonal Antibody (STMA00206) at 1:500 for 2 hours at RT with shaking.
Frequently bought together:

Description

Alpha Synuclein Antibody (pSer129) [J18]

Alpha Synuclein Antibody (pSer129) [J18] is a rabbit recombinant monoclonal antibody directed against Alpha Synuclein Antibody (pSer129), offered by Assay Genie for research applications. Reported applications include ELISA, WB, ICC and IHC. Reported reactivity: Human and Mouse. Supplied as IgG, purified by Affinity.

Alpha-synuclein (SNCA) is a neuronal protein predominantly expressed in the brain, where it is enriched at presynaptic terminals and plays a key role in synaptic function (1). It is also highly expressed in mitochondria-rich regions such as the olfactory bulb, hippocampus, striatum, and thalamus, suggesting a role in mitochondrial dynamics and neuronal energy metabolism (2). Functionally, alpha-synuclein interacts with tubulin (3), indicating a potential role as a microtubule-associated protein involved in cytoskeletal organization and intracellular transport. It is essential for cognitive development, with SNCA inactivation linked to impaired spatial learning and working memory (4). Pathologically, SNCA aggregates are a major non-Aβ component of amyloid plaques in Alzheimer’s disease and a defining feature of Lewy body inclusions in Parkinson’s disease (PD). PD is characterized by the progressive accumulation of alpha-synuclein and ubiquitin-positive inclusions in vulnerable neurons, contributing to neurodegeneration (5, 6). Critically, phosphorylation of alpha-synuclein at serine 129 (pSer129) is a key post-translational modification associated with disease pathology. Approximately 90% of alpha-synuclein found in Lewy bodies is phosphorylated at Ser129, compared to only a small fraction in the healthy brain (7, 8). This modification is widely used as a biomarker for pathological alpha-synuclein and is a focal point in therapeutic and diagnostic research targeting synucleinopathies. This antibody is also available conjugated to ATTO 390, ATTO 488, ATTO 594, APC, Biotin, FITC, HRP, PerCP and RPE. Supplied in 100 µg. For research use only; not for diagnostic or therapeutic procedures.

View AllClose

0 Reviews

View AllClose